Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast Cancer

30 Mar 2009

Abstract excerpt

Tamoxifen resistance is a major cause of death in patients with recurrent breast cancer. Current clinical factors can correctly predict therapy response in only half of the treated patients. Identification of proteins that are associated with tamoxifen resistance is a first step toward better response prediction and tailored treatment of patients. In the present study we intended to identify putative protein...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Advanced Proteomics Techniques and Applications
Share to Computational Drug Discovery Methods
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 19329653
DOI: 10.1074/mcp.m800493-mcp200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of a Putative Protein Profile Associated with Tamoxifen Therapy Resistance in Breast CancerPMID 19329653Read ↗

Biomarkers of chemotherapy resistance in breast cancer identified by proteomics: current status.Semantic proximity Read ↗

Differential gene expression in tamoxifen-resistant breast cancer cells revealed by a new analytical model of RNA-Seq data.Semantic proximity Read ↗

Discovery of Proteins Responsible for Resistance to Three Chemotherapy Drugs in Breast Cancer Cells Using Proteomics and Bioinformatics AnalysisSemantic proximity Read ↗

Path to drugging functional clones of luminal breast cancers using in-depth proteomics with spatially resolved mass spectrometry guided by MALDI imagingSemantic proximity Read ↗

Metastasis-related Plasma Membrane Proteins of Human Breast Cancer Cells Identified by Comparative Quantitative Mass SpectrometrySemantic proximity Read ↗

Differential Proteomic Analysis of Late-Stage and Recurrent Breast Cancer from Formalin-Fixed Paraffin-Embedded TissuesSemantic proximity Read ↗

Breast cancer proteomics by laser capture microdissection, sample pooling, 54-cm IPG IEF, and differential iodine radioisotope detection.Semantic proximity Read ↗

Mass spectrometry (LC-MS/MS) identified proteomic biosignatures of breast cancer in proximal fluid.Semantic proximity Read ↗

Proteomic analysis in human breast cancer: Identification of a characteristic protein expression profile of malignant breast epitheliumSemantic proximity Read ↗

Identification of Novel Molecular Targets for Endometrial Cancer Using a Drill-Down LC-MS/MS Approach with iTRAQSemantic proximity Read ↗

Characterizing the Relapse Potential in Different Luminal Subtypes of Breast Cancers with Functional ProteomicsSemantic proximity Read ↗

Association of tamoxifen resistance and lipid reprogramming in breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.